Allergologie /

Dr. med. Marianne Lerch

Chefärztin Allergologie/Dermatologie
Fachärztin für Dermatologie und Venerologie
Fachärztin für Allergologie und klinische Immunologie

2008Facharzttitel FMH Allergologie/Klinische Immunologie
2004Facharzttitel FMH Dermatologie/Venerologie
1995Dissertation, Med. Fakultät, Universität Bern. Titel: ‚Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes’
1994Eidg. Arztdiplom, Med. Fakultät, Universität Bern


  1. Daubner B, Groux-Keller M, Hausmann O V, Kawabata T, Naisbitt D J, Park B K, Wendland T, Lerch M, Pichler W J.
    Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells.
    Allergy 2012; 67:58-66.
  2. Keller M*, Lerch M*, Britschgi M, Tâche V, Gerber B O, Lüthi M, Lochmatter P, Kanny G, Bircher A J, Christiansen C, Pichler W J.
    Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells.
    Clin Exp Allergy 2010; 40:257-68. (*equally contributing authors)
  3. Zawodniak A, Lochmatter P, Yerly D, Kawabata T, Lerch M, Yawalkar N, Pichler W J.
    In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases.
    Allergy 2010; 65:376-84.
  4. Brockow K, Romano A, Aberer W, Bircher A J, Barbaud A, Bonadonna P, Faria E, Kanny G, Lerch M, Pichler W J, Ring J, Rodrigues Cernadas J, Tomaz E, Demoly P, Christiansen C,
    European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity . Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study.
    Allergy 2009; 64:234-41.
  5. Lerch M, Keller M, Britschgi M, Kanny G, Tache V, Schmid D A, Beeler A, Gerber B O, Luethi M, Bircher A J, Christiansen C, Pichler W J.
    Cross-reactivity patterns of T cells specific for iodinated contrast media.
    The Journal of Allergy and Clinical Immunology 2007; 119:1529-36.
  6. Pichler W J, Beeler A, Keller M, Lerch M, Posadas S, Schmid D, Spanou Z, Zawodniak A, Gerber B.
    Pharmacological interaction of drugs with immune receptors: the p-i concept.
    Allergology International : official journal of the Japanese Society of Allergology 2006; 55:17-25.
  7. Beltraminelli H S, Lerch M, Arnold A, Bircher A J, Haeusermann P.
    Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature.
    The British Journal of Dermatology 2005; 152:780-3.
  8. Lerch M, Egger C, Bircher A J.
    Allergic reactions to macadamia nut.
    Allergy 2005; 60:130-1.
  9. Lerch M, Pichler W J. The immunological and clinical spectrum of delayed drug-induced exanthems.
    Current Opinion in Allergy and Clinical Immunology 2004; 4:411-9.
  10. Lerch M, Bircher A J. Systemically induced allergic exanthem from mercury.
    Contact Dermatitis 2004; 50:349-53.
  11. Teuscher A U, Weidmann P, Lerch M, Laissue J A.
    Nephropathy subsequent to hyperlipidemia.
    Clinical Nephrology 2000; 54:64-7.
  12. Lerch M, Weidmann P, Ho M P, Gerber P, Eckenberger P, Kaemmereit A, Teuscher A U.
    Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.
    Journal of Cardiovascular Pharmacology 1999; 33:527-33.
  13. Teuscher A U, Lerch M, Shaw S, Pacini G, Ferrari P, Weidmann P.
    Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men.
    Journal of Hypertension 1998; 16:1279-84.
  14. Lerch M, Teuscher A U, Beissner P, Schneider M, Shaw S G, Weidmann P.
    Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.
    Journal of Cardiovascular Pharmacology 1998; 31:576-80.
  15. Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Riesen W, Weidmann P.
    Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
    Journal of Hypertension 1996; 14:669-77.


  1. Lerch M.
    Drug-induced angioedema; in French L E (ed): Adverse Cutaneous Drug Eruptions.
    Chem Immunol Allergy. Basel, Karger, 2012, vol 97, pp 98–105.